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Artiﬁcial membrane-binding proteins stimulate
oxygenation of stem cells during engineering of
large cartilage tissue
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Restricted oxygen diffusion can result in central cell necrosis in engineered tissue, a problem
that is exacerbated when engineering large tissue constructs for clinical application.
Here we show that pre-treating human mesenchymal stem cells (hMSCs) with synthetic
membrane-active myoglobin-polymer–surfactant complexes can provide a reservoir of
oxygen capable of alleviating necrosis at the centre of hyaline cartilage. This is achieved
through the development of a new cell functionalization methodology based on
polymer–surfactant conjugation, which allows the delivery of functional proteins to the hMSC
membrane. This new approach circumvents the need for cell surface engineering using
protein chimerization or genetic transfection, and we demonstrate that the surface-modiﬁed
hMSCs retain their ability to proliferate and to undergo multilineage differentiation. The
functionalization technology is facile, versatile and non-disruptive, and in addition to tissue
oxygenation, it should have far-reaching application in a host of tissue engineering and
cell-based therapies.
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I
n vitro tissue engineering is emerging as a key strategy for
the replacement of damaged or diseased tissue1. A typical
approach is to immobilize stem cells on a porous scaffold,
and induce differentiation and extracellular matrix secretion.
However, it has been demonstrated that respiring cells on the
scaffold periphery can restrict oxygen availability at the centre of
the tissue, leading to areas of cell necrosis and tissue degradation2.
Moreover, the poor solubility and low diffusion rate of oxygen in
aqueous media results in a critical diffusion length of around
200mm, which severely limits the size of engineered tissue
constructs3. Mechanical compression4 and ﬂow perfusion5
can enhance oxygen transport through scaffolds; however,
these dynamic culture conditions can negatively impact cell
differentiation and tissue formation6. Neovascularisation7 and
tissue printing8 strategies allow the engineering of capillary
architecture, although these approaches are beneﬁcial only after
the engineered tissue integrates with physiological vasculature.
A different strategy, which has shown much promise, is the
provision of oxygenating species within the tissue construct. For
instance, cell viability can be enhanced by using scaffolds
impregnated with calcium peroxide, which forms oxygen in a
gradual decomposition reaction9.
The new approach described herein, however, utilizes the
hyperbolic oxygen-binding proﬁle of myoglobin to create a
responsive system, with oxygen release triggered only under
hypoxic conditions. In this work, a novel polymer–surfactant
complex of myoglobin is delivered to the cytoplasmic membrane
of stem cells, which are then used to engineer hyaline cartilage
constructs with signiﬁcantly enhanced matrix distribution at the
centre of the tissue. This direct cell oxygenation methodology
circumvents the size limitations imposed by diffusion limited
mass transport and should enable in vitro engineering of not only
large cartilage constructs, but also other tissues, such as cardiac or
bone. Furthermore, this new ‘cell priming’ methodology is
versatile, and contains the synthetic ﬂexibility to allow it to be
readily applied to other proteins and cell types for applications
beyond tissue oxygenation, such as cell imaging, homing or
signalling.
Results
Synthesis of protein–surfactant complexes. Membrane-binding
complexes were prepared using enhanced green ﬂuorescent
protein (eGFP), to study membrane afﬁnity, and myoglobin
(Mb), to promote tissue oxygenation. The reproducible two-step
synthesis involved the covalent coupling of acidic amino acid
residues with N,N0-dimethyl-1,3-propanediamine (DMPA) to
form the cationized proteins [eGFP_C] and [Mb_C], which were
electrostatically conjugated to the anionic polymer–surfactant
glycolic acid ethoxylate 4-nonylphenyl ether (H19C9-Ph-O-
(CH2CH2O)40-CH2-COO-, S) to produce the hybrid complexes
[eGFP_C][S] and [Mb_C][S]. Cationization efﬁciencies were
evaluated using mass spectrometry (Supplementary Table 1), and
corresponded to the addition of 20 and 13 DMPA molecules for
[eGFP_C] and [Mb_C], respectively. Zeta potential measure-
ments conﬁrmed that cationization formed a species with positive
surface charge, which was neutralized after surfactant conjugation
(Supplementary Table 2). Dynamic light scattering measurements
revealed a 1–2 nm increase in hydrodynamic radii after surfactant
conjugation (Supplementary Table 3), consistent with a protein
surrounded by a compact polymer–surfactant corona.
A range of spectroscopic and binding studies were undertaken
to elucidate the structure and function of the complexes.
Synchrotron radiation circular dichroism (SRCD) spectroscopy
experiments revealed that the surface modiﬁcations had no effect
on the secondary and tertiary structure of [eGFP_C][S], with
characteristic b-barrel structural absorbance peaks at 196 and
217 nm (Supplementary Fig. 1a,b). Thermal denaturation melting
curves (l¼ 196 nm) performed on [eGFP_C][S] yielded a half
denaturation temperature of 73 C (compared with 76 C for
eGFP), which represents only a slight reduction in thermal
stability (Supplementary Fig. 1c). Antibody binding studies
provided further evidence of the structural integrity of
[eGFP_C][S], with the complexes able to bind anti-GFP
functionalized beads (Supplementary Fig. 2). Ultraviolet–visible
and ﬂuorescence spectroscopy measurements demonstrated that
[eGFP_C][S] retained the native optical function of eGFP, with
an absorbance band at 488 nm and a corresponding emission
peak at 508 nm (Supplementary Fig. 3). SRCD spectra of
[Mb_C][S] showed characteristic a-helical features at 208 and
222 nm, albeit with reduced molar ellipticity when compared with
native Mb (Supplementary Fig. 4). Ultraviolet–visible spectro-
scopy analysis measured ferric, oxyferrous and deoxyferrous Soret
bands at 411, 414 and 424 nm, respectively. Interestingly, these
peaks more closely resemble neuroglobin (411, 413 and
424 nm)10,11 than native myoglobin (408, 416 and 433 nm;
Supplementary Fig. 5), an observation that can be rationalized by
small structural changes in the vicinity of the haem. Signiﬁcantly,
equilibrium oxygen-binding results showed [Mb_C][S] to possess
a higher oxygen afﬁnity than native myoglobin, with a
dissociation constant of 2.4 10 6M (compared with
1.2 10 5M for Mb; Supplementary Fig. 6).
Membrane afﬁnity of protein–surfactant complexes. The
complexes were designed to display an amphiphilic polymer–
surfactant corona to facilitate delivery to the cytoplasmic
membrane (Fig. 1a). Flow cytometry measurements performed on
human mesenchymal stem cells (hMSCs) incubated with 18 mM
[eGFP_C][S] at 37 C showed extensive labelling, while negligible
membrane interactions were observed for the native eGFP control
(Supplementary Fig. 7). Moreover, further analysis of the depleted
supernatant revealed a saturation level of approximately six
billion [eGFP_C][S] complexes per cell (Supplementary Fig. 8).
Reducing the incubation temperature to 4 C reduced the label-
ling efﬁciency of [eGFP_C][S], while pre-treatment of hMSCs
with sodium chlorate, an inhibitor of anionic proteoglycan
synthesis, did not affect membrane afﬁnity (Supplementary
Fig. 9). These results are consistent with a hydrophobic associa-
tion mechanism, whereby the nonylphenyl tail within the
surfactant corona inserts into the phospholipid membrane
bilayer. The intermediate species [eGFP_C] was also capable of
labelling hMSCs, albeit in a contrasting mechanism mediated by
electrostatic attraction to sulfated proteoglycans, an observation
consistent with studies of supercharged proteins12. Importantly,
the total ﬂuorescence intensity from the [eGFP_C][S]-labelled
cells was twofold greater than that from the equivalent [eGFP_C]
system (Supplementary Fig. 10), which suggested that there were
approximately twice as many functional complexes at the cell
membrane. Moreover, hMSCs retained [eGFP_C][S] for up to 10
days in culture; in contrast, [eGFP_C] labelled the hMSCs for
o6 days (Fig. 1b). Inhibition assays revealed clathrin-mediated
endocytosis to be responsible for the internalization and
proteolysis of both [eGFP_C] and [eGFP_C][S] (Supplementary
Fig. 11).
Cell viability assays revealed no cytotoxic effects of the priming
process (Supplementary Fig. 12) and cell counts showed that
labelled hMSCs retained their ability to undergo self-renewal
(Supplementary Fig. 13). In addition, the labelled hMSCs were
able to undergo adipogenesis, osteogenesis and chondrogenesis
(Supplementary Figs 14,15). Live cell confocal ﬂuorescence
microscopy was used to observe [eGFP_C][S] at the hMSC
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cytoplasmic membrane for up to 120 h post incubation (Fig. 1c–g
and Supplementary Fig. 16). A three-dimensional image
reconstruction revealed discrete clusters of [eGFP_C][S] at the
cell membrane, suggesting lateral diffusion and accumulation
into clathrin-coated pits, further evidence that the complex is
endocytosed by clathrin-mediated endocytosis (Supplementary
Fig. 17). Signiﬁcantly, experiments using a ﬂuorescent myoglobin
analogue, [Zn-Mb_C][S], also showed efﬁcient labelling of
hMSCs (Fig. 1h). This indicated that the cell functionalization
methodology could be readily applied to myoglobin, which was
used to alleviate hypoxia during in vitro tissue engineering.
Oxygenation of hMSCs during cartilage tissue engineering.
Cartilage was selected as a model system, as recent work has
demonstrated that severe oxygen gradients present during tissue
engineering can impact cell viability and tissue formation13.
hMSCs were seeded onto large, cylindrical felt discs (5mm
diameter and 6mm depth) made from polyglycolic acid (PGA),
a commonly-used scaffold material for cartilage tissue
engineering14 (Supplementary Fig. 18). Confocal ﬂuorescence
microscopy performed after seeding showed cells distributed
throughout the scaffold (Supplementary Fig. 19). The uniformity
of seeding was conﬁrmed by RNA measurements, which revealed
that the inner 36% of the scaffold contained 32±3% of the
hMSCs (Supplementary Fig. 20). Despite this, cartilage
engineered using this protocol led to the formation of tissue
with poor matrix formation, or even large voids, at the centre of
the engineered construct (Fig. 2a–d and Supplementary Fig. 21).
Although it is possible that histological processing could have
ampliﬁed the size of the voids, these observations are consistent
with the occurrence of hypoxia-related central cell necrosis.
Signiﬁcantly, pre-treating hMSCs with 18 mM [Mb_C][S]
reduced the size of the necrotic core from 42±24 to 7±6%
(Supplementary Fig. 22). Furthermore, quantitative biochemical
assays revealed that myoglobin priming produced a twofold
increase in the type II: type I collagen ratio, a measure of hyaline
cartilage quality (Fig. 2e and Supplementary Fig. 23).
These observed increases in tissue quality and distribution
could be rationalized by the presence of membrane-bound
[Mb_C][S] supplying a reservoir of oxygen to cells at the centre
of the cartilage construct. This oxygenation hypothesis is
supported by the observation that pre-treatment with an
analogous [apo-Mb_C][S] complex unable to bind oxygen did
not reduce the size of the necrotic core (30±6%), nor enhance
the cartilage quality. Raman microscopy measurements on
hMSCs labelled with [Mb_C][S] indicated the presence of an
oxyferrous haem, with characteristic peaks observed at
1585 and 1637 cm 1 (Fig. 3)15. With B5.9 109 oxygenated
complexes per cell, each tissue construct would be expected to
contain around 7.1 1015 additional dioxygen molecules. On the
basis of consumption rate of 0.8 10 19mol cell 1 s 1 for
chondrocytes seeded on polymeric scaffolds16, the exogenous
myoglobin provides an additional 34 h of oxygen per cell to
supplement the environmental oxygen already available to the
tissue (Supplementary Methods). Furthermore, the equilibrium
binding proﬁle of [Mb_C][S] suggests a net release of oxygen only
under extreme hypoxia ([O2]o1.4%), corresponding to the
oxygen tensions observed within the inner core of cartilage
constructs. The expression of known hypoxia genes was measured
by quantitative PCR (qPCR) using RNA extracted from the
central portion of cartilage engineered with either untreated
hMSCs or myoglobin-primed hMSCs (Supplementary Fig. 24).
A general trend was observed, whereby the majority of HIF1a and
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Figure 1 | Membrane interactions of the protein–polymer-surfactant complexes. (a) Schematic showing that in solution, the polymer–surfactant corona
surrounding myoglobin (cyan) adopts a compact conformation with the hydrophobic nonylphenyl tails (red) buried by the poly(ethylene glycol) chains
(yellow). Contact with the hydrophobic phospholipid bilayer results in a conformational reorganization of the corona that allows the alkyl chains to
anchor the complex to the cell membrane. (b) Persistent membrane afﬁnity was demonstrated using ﬂow cytometry. [eGFP_C][S]-labelled hMSCs were
observed for up to 10 days in culture (red trace), whereas the membrane-bound [eGFP_C] was cleared within 6 days (blue trace). Live cell confocal
ﬂuorescence microscopy images showing [eGFP_C][S] localized at the cytoplasmic membrane of hMSCs (c) immediately after priming, (d) after 24 h,
(e) 48 h, (f) 72 h and (g) 120 h. (h) Analogous experiments revealed membrane-bound [Zn-Mb_C][S] immediately after priming. The scale bar in all
confocal microscopy images is equal to 25mm.
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downstream hypoxia genes were downregulated in the
myoglobin-primed cells after 1 and 7 days of tissue engineering,
with signiﬁcant downregulation observed for the expression of
PRKAA2, MB and IGFBP1. This gene analysis suggests that the
beneﬁcial effect of priming occurs during the initial stages of
chondrogenesis and cartilage formation, which is consistent with
the labelling period of 10 days observed for [eGFP_C][S]-labelled
hMSCs. After 14 days of tissue engineering, however, many
hypoxia genes were signiﬁcantly upregulated in the myoglobin-
primed cells, including ATP1B1, BHLHE40, EGLN1, EPAS1 and
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Figure 2 | Hyaline cartilage engineering using protein–polymer-surfactant complexes. Constructs of hyaline cartilage were engineered using (a)
unlabelled hMSCs, (b) hMSCs primed with [Mb_C][S] and (c) hMSCs primed with [apo-Mb_C][S]. In each case the engineered cartilage was macroscopically
similar, with a diameter of B5mm. (d) Sections taken from the centre of the cartilage constructs (scale bars equal to 1mm) were stained for
glycosaminoglycan using safranin O, while immunohistochemistry was used to localize type II collagen. Pre-treatment of hMSCs with [Mb_C][S] produced
cartilage with signiﬁcantly decreased central necrosis, compared with the cartilage engineered using unlabelled and [apo-Mb_C][S]-treated hMSCs.
(e) Enzyme-linked immunosorbent assays on trypsin-digested constructs revealed a signiﬁcant increase in type II collagen: type I collagen ratio for the cartilage
grown using cells primed with [Mb_C][S], while no signiﬁcant changes were observed in the [apo-Mb_C][S] system. Data is presented as a mean and
standard deviation from seven biological replicates. Comparison of differences was measured usingWilcoxon non-parametric paired analysis, with two-tailed P-
value of o0.05 considered signiﬁcant and denoted with an asterisk. For full biochemical and histological analysis, please refer to Supplementary Figs 17–19.
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Figure 3 | Monitoring the oxidation state of membrane-bound [Mb_C][S]. Raman microscopy scans superimposed over bright ﬁeld microscopy images
(light blue) of ovine mesenchymal stem cells (oMSCs) treated with (a) [apo-Mb_C][S] or (b) [Mb_C][S] (scale bars equal to 10mm). oMSCs treated with
[apo-Mb_C][S] exhibited a homogenous biochemical proﬁle (red), while the hMSCs treated with [Mb_C][S] revealed two major chemical proﬁles; one
with high intensity at 1,585 cm 1 (purple) and another with a proﬁle similar to the [apo-Mb][S] control (green). (c) Multivariate curve resolution-
alternative least squares (MCR-ALS) analysis was used to deconvolute the Raman spectra from ﬁve different cell maps. This revealed that the [Mb_C][S]
system possessed a major component with peaks centred at 1,585 and 1,637 cm 1 (purple trace). This component corresponded to the spectral ﬁngerprint
of oxyferrous myoglobin, which has peaks reported at 1,585 and 1,640 cm 1 that are absent in the Raman spectra of deoxyferrous and ferric myoglobin15. A
background spectral component was recorded for both the [Mb_C][S] and [apo-Mb_C][S] systems (green and red traces, respectively). Taken together,
these data are consistent with oxyferrous myoglobin clustered within clathrin-coated pits at the cell membrane.
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SOD3. These network changes, which may be attributed to
a dosage compensation effect17, could even be responsible for
the higher type II: type I collagen ratio produced in the
tissue engineered with [Mb_C][S]-primed hMSCs. Given the
complexity of hypoxia homoeostasis and adaptation in cells18,19,
it is perhaps not surprising that deﬁnable transcriptional changes
as a result of treatment may not perturb an individual network of
genes in a non-binary and static fashion20. For instance, although
some biomimetic studies have demonstrated that hypoxia can
enhance chondrogenesis and chondrocyte proliferation, these
results support a large body of recent work showing that oxygen
is an essential nutrient in cartilage development and tissue
formation21. Moreover, these results mirror recent work showing
that ectopic expression of myoglobin in carcinoma cells can
reduce oxygen deprivation in experimental tumour models22
and that endogenous myoglobin upregulation can act to protect
non-muscle tissues against hypoxic stress23. The results presented
here, however, represent the ﬁrst example of myoglobin used to
alleviate hypoxia in a tissue engineering context.
In conclusion, we report on a new class of protein-polymer–
surfactant complexes that possess non-native membrane
afﬁnity, which offer a versatile alternative to performing cell
surface chemistry24, chimerization biotechnology25 or genetic
manipulation26. The methodological ﬂexibility arises from the
synthetic design of the surfactant corona, in this case a
hydrophobic nonylphenyl tail was utilized to facilitate effective
and persistent membrane afﬁnity, while the signiﬁcant
polyethylene oxide segment increased the local dielectric
constant and prevented protein denaturation. We have applied
this technology to in vitro tissue engineering and shown that
pre-treating mesenchymal stem cells with myoglobin complexes
can improve the tissue distribution and biochemical composition
of hyaline cartilage. The myoglobin complexes exhibit a tight,
non-linear binding proﬁle, which allows oxygen to remain bound
under mild hypoxia, and then release oxygen only when levels are
critically low. Here, this technology was utilized to alleviate
hypoxia during in vitro tissue engineering, and any subsequent
implantation would require integration and the adoption of
physiological oxygenation mechanisms such as compression-
aided convection or vascularization. The versatility of this new
cell functionalization process, however, will enable a wide range
of functional proteins to be delivered to a variety of cell types.
This will have signiﬁcant impact not only on regenerative
medicine, but on a host of cell-based therapies, with potential
applications including tracking the migration and integration of
transplanted cells using ﬂuorescent proteins, promoting
juxtracrine signalling cascades with interactive ligands and
targeting tissues or tumours using antibodies.
Methods
Protein modiﬁcation. All chemicals were purchased from Sigma Aldrich, UK,
unless stated otherwise. eGFP was recombinantly expressed using BL21-competent
Escherichia coli and puriﬁed using metal ion afﬁnity chromatography. Equine heart
Mb was used as purchased, or modiﬁed using a 2-butanone solvent extraction and
dialysis to produce apo-Mb, followed by reconstitution with protoporphyrin IX
zinc (II) in dimethylsulfoxide to yield Zn-Mb. For full details of protein expression
and modiﬁcations, see Supplementary Methods. Solutions (5mgml 1) of eGFP,
Mb, apo-Mb or Zn-Mb were ﬁltered with a 0.22 mm syringe ﬁlter then added to a
100mgml 1 solution of DMPA at pH 7. The solutions were stirred for 4 h at
pH 6.9, and then solid N-(3-Dimethylaminopropyl)-N0-ethylcarbodiimide hydro-
chloride (EDC) was added and the solution stirred for a further 24 h at pH 6.6 for
eGFP and pH 6.0 for Mb, apo-Mb or Zn-Mb. The cationized protein samples were
then ﬁltered with a 0.22 mm syringe ﬁlter and dialyzed overnight into 20mM buffer
solutions (phosphate buffer at pH 7.0 for [eGFP_C] and HEPES buffer at pH 8.0
for [Mb_C], [apo-Mb_C] and [Zn-Mb_C]). The ratio of DMPA and EDC to the
native protein anionic residues was kept consistent at 150 and 34, respectively, to
promote high cationization efﬁciencies. The cationized proteins were conjugated at
a ratio of 1.4 surfactant chains per cationic residue, by stirring the protein for 24 h
in with a 10mgml 1 solution of oxidized IGEPAL CO-890 dissolved in 20mM of
the corresponding buffer. For details of surfactant synthesis and the biophysical
characterization of modiﬁed proteins, see Supplementary Methods.
Cell culture. hMSCs were harvested from the proximal femur bone marrow of
osteoarthritic patients undergoing total hip replacement surgery, in full accordance
with Bristol Southmead Hospital Research Ethics Committee guidelines (reference
#078/01) and with informed consent from all patients. Ovine mesenchymal stem
cells (oMSCs) were obtained from bone marrow of sheep at the Royal Veterinary
College (University of London, UK). All cells were cultured at 37 C and 5% carbon
dioxide using expansion media comprised of low glucose (1000mg dm 3)
DMEM containing pyridoxine–HCl and NaHCO3 with 100 units ml 1 penicillin,
100 mgml 1 streptomycin, 2mM GlutaMAX supplement (Invitrogen, USA),
10% (v/v) foetal bovine serum and 5 ngml 1 freshly supplemented basic human
ﬁbroblast growth factor (Peprotech, USA). Media was replenished every 2–3 days
and at B80% conﬂuency, the cells were passaged using Dulbecco’s PBS and
trypsin/EDTA solution, up to a passage number of ﬁve.
Cell priming. Expansion media was aspirated and replaced with 18 mM of
[eGFP_C][S], [Mb_C][S], [apo-Mb_C][S] and [Zn-Mb_C][S] in 20mM of the
corresponding buffer. Protein–surfactant complex (7ml) was used for T175 ﬂasks,
1ml for T25 ﬂasks (Appleton Woods, UK) and 0.5ml for 35mm diameter
Petri dishes with glass (MatTek, USA) or calcium ﬂuoride (CrysTran Ltd, UK)
substrates. The cells were incubated at 37 C for 30min, the solution was aspirated,
and then the cells were washed using an equivalent volume of 0.04mgml 1
heparin ammonium salt (Sigma Aldrich, UK) in PBS to remove any unbound
complex. The primed cells were then analysed or returned to culture in expansion
media at 37 C. Control experiments were performed using identical conditions
with PBS or native and cationized protein analogues. For details of the analysis of
the primed cells, including ﬂow cytometry, confocal microscopy and Raman
spectroscopy, see Supplementary Methods.
Cell viability assay. Cytotoxicity was assessed by priming hMSCs with
protein–surfactant complex or PBS, culturing the cells at 37 C for 24 h and then
adding CellTiter 96 solution (Promega, USA) to the expansion media for 2 h. The
absorbance at 488 nm was measured, and the cell survival of the primed hMSCs
were normalized with respect to the PBS-treated cells. For full details of the cell
viability assay see Supplementary Methods.
Proliferation assay. Proliferation was assessed by priming hMSCs with
protein–surfactant complex or PBS, culturing the cells at 37 C for 24 h and then
seeding 100,000 cells into T25 ﬂasks. The cells were harvested and counted after
7 or 14 days in culture, and the population doublings of the primed hMSCs were
normalized with respect to the PBS-treated cells. For full details of the proliferation
assay see Supplementary Methods.
Differentiation assays. Osteogenesis and adipogenesis were assessed in
monolayer by priming hMSCs with protein–surfactant complex or PBS, culturing
the cells at 37 C for 24 h and then inducing differentiation using minimum
essential medium containing NaHCO3 with 100 unitsml 1 penicillin,
100 mgml 1 streptomycin, 2mM GlutaMAX supplement, 10% (v/v) FBS and
50 ml ml 1 of freshly-added osteogenic or adipogenic supplement (R&D Systems,
UK). The hMSCs were cultured under these conditions for 3 weeks, with media
changes twice a week. The hMSCs were then ﬁxed and stained with either Alazarin
Red (osteogenesis) or Oil Red (adipogenesis). Chondrogenesis was assessed by
priming hMSCs with protein–surfactant complex or PBS, culturing the cells at
37 C for 24 h, and then engineering cartilage tissue. For full differentiation studies
see Supplementary Methods.
Cartilage tissue engineering. Cartilage tissue engineering was performed using
non-woven Biofelt PGA scaffolds with a density of 45mg cc 1, a ﬁbre thickness
of 20mm (Biomedical Structures, USA), a 5mm diameter and a thickness of
either 2mm (for [eGFP_C][S] chondrogenesis study) or 6mm (for [Mb_C][S]
oxygenation study). The scaffolds were sterilized by ethylene oxide treatment
(Anderson Caledonia, UK) and then by a 5min immersion in 100% ethanol. The
scaffolds were washed three times with PBS, immersed for 30min in 100 mgml 1
ﬁbronectin/PBS solution, dried overnight and added to individual inner wells of a
24-well plate coated with 1ml of sterile 10mgml 1 agarose per well. The scaffolds
were immersed for 30min in 1ml of expansion media, with all bubbles were
removed by gently squeezing the scaffolds. The media was completely removed
from the scaffold, which was then stood upright and seeded from the top
with a 30ml suspension of 300,000 hMSCs for the 2 5mm scaffolds, or a 90ml
suspension of 1,200,000 hMSCs for the 6 5mm scaffolds. These cells had either
been primed with PBS, [eGFP_C][S], [Mb_C][S] or [apo-Mb_C][S] 24 h before
seeding. Empty wells of the 24-well plate were ﬁlled with sterile antifungal water
containing 100 unitsml 1 penicillin, 100mgml 1 streptomycin and 2.5 mgml 1
amphotericin B, and then the plate was incubated overnight at 37 C. The scaffolds
were then turned over and returned to the incubator for 2 h at 37 C.
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Differentiation was induced through the addition of chondrogenic media
comprising high glucose (4,500mgdm 3) DMEM containing pyridoxine–HCl and
NaHCO3 with 100 unitsml 1 penicillin, 100mgml 1 streptomycin, 2mM
GlutaMAX supplement, 1% (v/v) insulin transferrin selenium solution, 1mM
sodium pyruvate, freshly supplemented with 100 nM dexamethasone, 80 mM
ascorbic acid-2-phosphate and 10 ngml 1 transforming growth factor b3. The
2 5mm scaffolds required 1ml of differentiation media and the 6 5mm
scaffolds required 1.5ml of differentiation media. The 24-well plate was incubated
at 37 C on a rotating platform, with media changes three times a week, and after
7 days, the media was supplemented with 10 mgml 1 human pancreatic insulin to
promote matrix secretion. The constructs were harvested after 35 days for
histological and biochemical analysis, or at earlier intervals for qPCR. For each
condition tested, two constructs were digested for biochemical analysis, one was
sectioned for histology, and two were processed for qPCR.
Biochemical analysis. Engineered cartilage constructs were pooled, lyophilized
and digested at 37 C overnight and 67 C for 3 h using 250–1,000 ml of digestion
solution containing 2mgml 1 L-(tosylamido-2-phenyl) ethyl chloromethyl ketone
(TCPK)-treated trypsin, 1mM EDTA, 1mM iodoacetamide, 0.02mgml 1 pep-
statin A and 50mM Tris-HCl at pH 7.2. The cartilage digest was then boiled for
15min at 100 C, centrifuged for 2min at 15,000g and then analysed for GAG
using a chondroitin sulfate assay or type I or type II collagen using enzyme-linked
immunosorbent assays. For full details of digestion and biochemical assays, see
Supplementary Methods.
Histological analysis. Engineered cartilage constructs were ﬁxed overnight using
40mgml 1 paraformaldehyde in PBS, immersed in 70% ethanol (v/v) for 2 h and
then submitted to the Histology Services Unit (University of Bristol). Here, the
cartilage was embedded in parafﬁn wax, and 3mm sections were taken from the
centre of the tissue and afﬁxed to polysine microscope slides (VWR, UK). The
cartilage sections were stained using haematoxylin and eosin, safranin O, while
immunohistochemistry was used to locate type I collagen and type II collagen. Images
were captured using a DMI 3,000 optical microscope (Leica, UK) and image analysis
was performed on safranin O sections using Image J (National Institute of Health,
USA). For full details of staining and image analysis, see Supplementary Methods.
RNA extraction and qPCR analysis. Engineered cartilage constructs were washed
with PBS and the inner tissue segment was isolated using a 3mm biopsy punch
(Stiefel Laboratories, USA) before RNA extraction using a Total RNA Puriﬁcation
Kit (Norgen Biotek Corp, Canada). RNA concentration was measured using a
DU530 spectrophotometer (Beckmann Coulter, USA) and a maximum of 2,000 ng
of RNA was used to synthesize 40 ml of cDNA using a PrimeScript RT reagent kit
(Takara, Japan) and a MJ Mini thermal cycler (BioRad Laboratories, USA) with a
37 C and 85 C annealing and denaturation temperature, respectively. qPCR was
performed using a 7500 real-time Applied Biosystems Detection System and
96-well human hypoxia Taqman array plates (Life Technologies, USA, Catalogue
Number 4418735) with the cDNA template diluted to 50 ng ml 1. For full details of
RNA extraction and qPCR analysis, see Supplementary Methods.
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